<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" 
  xmlns:dc="http://purl.org/dc/elements/1.1/"
  xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
  xmlns:admin="http://webns.net/mvcb/"
  xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#">

<channel>
<title>In the Pipeline</title>
<link>/home/corante/public_html/pipeline/</link>
<description></description>
<dc:language>en-us</dc:language>
<dc:creator>derekb.lowe@gmail.com</dc:creator>
<dc:date>2012-11-02T07:20:41-05:00</dc:date>
<admin:generatorAgent rdf:resource="http://www.movabletype.org/?v=3.34" />
<sy:updatePeriod>hourly</sy:updatePeriod>
<sy:updateFrequency>1</sy:updateFrequency>
<sy:updateBase>2000-01-01T12:00+00:00</sy:updateBase>

<item>
<title>Sudden Onset of Promiscuity</title>
<link>http://pipeline.corante.com/archives/2012/11/02/sudden_onset_of_promiscuity.php</link>
<description>That title should bring in the hits. But don&apos;t get your hopes up! This is medicinal chemistry, after all. &quot;Can&apos;t you just put the group in your molecule that does such-and-such?&quot; Medicinal chemists sometimes hear variations of that question from...</description>
<guid isPermaLink="false">75978@/home/corante/public_html/pipeline/</guid>
<dc:subject>Drug Assays</dc:subject>
<dc:date>2012-11-02T07:20:41-05:00</dc:date>
</item>
<item>
<title>Kibdelomycin, A New Antibiotic. In A Way.</title>
<link>http://pipeline.corante.com/archives/2011/08/26/kibdelomycin_a_new_antibiotic_in_a_way.php</link>
<description>We&apos;re going to need new antibiotics. Everyone knows this, and it&apos;s not like no one&apos;s been trying to do anything about it, either, but. . .we&apos;re still going to need more of them than we have. I&apos;m not predicting that...</description>
<guid isPermaLink="false">75154@/home/corante/public_html/pipeline/</guid>
<dc:subject>Infectious Diseases</dc:subject>
<dc:date>2011-08-26T07:32:17-05:00</dc:date>
</item>
<item>
<title>Chiral What? Chiral How?</title>
<link>http://pipeline.corante.com/archives/2010/12/15/chiral_what_chiral_how.php</link>
<description>Thanks to an email from a reader, I can bring you this very weird paper from Tetrahedron. The authors claim to have extracted a local plant and isolated nevirapine, (sold as Viramune by Boehringer Ingleheim as a reverse transcriptase inhibitor...</description>
<guid isPermaLink="false">74795@/home/corante/public_html/pipeline/</guid>
<dc:subject>The Scientific Literature</dc:subject>
<dc:date>2010-12-15T08:36:45-05:00</dc:date>
</item>
<item>
<title>And One Was Just Right?</title>
<link>http://pipeline.corante.com/archives/2010/11/11/and_one_was_just_right.php</link>
<description>I&apos;ve been reading an interesting new paper from Stuart Schreiber&apos;s research group(s) in PNAS. But I&apos;m not sure if the authors and I would agree on the reasons that it&apos;s interesting. This is another in the series that Schreiber has...</description>
<guid isPermaLink="false">74754@/home/corante/public_html/pipeline/</guid>
<dc:subject>Academia (vs. Industry)</dc:subject>
<dc:date>2010-11-11T07:29:33-05:00</dc:date>
</item>
<item>
<title>Vinca Alkaloids, And Where They End Up</title>
<link>http://pipeline.corante.com/archives/2010/08/26/vinca_alkaloids_and_where_they_end_up.php</link>
<description>The Vinca alkaloids are some of the most famous chemotherapy drugs around - vincristine and vinblastine, the two most widely used, are probably shown in every single introduction to natural products chemistry that&apos;s been written in the past fifty years....</description>
<guid isPermaLink="false">74639@/home/corante/public_html/pipeline/</guid>
<dc:subject>Biological News</dc:subject>
<dc:date>2010-08-26T09:04:05-05:00</dc:date>
</item>


</channel>
</rss>